ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 772–779
DOI: 10.46882/AJIDR/149014
Article Type: Research Article
Title: Genomic surveillance and ceftazidime-avibactam susceptibility of KPC-producing Enterobacter cloacae complex in intensive care units
Names of Authors: Kemi Adewale¹*, Bjorn Lindqvist², Sanjay Kulkarni³
Abstract: Carbapenem-resistant Enterobacter cloacae complex has emerged as an important nosocomial pathogen capable of causing severe bloodstream and device-related infections. We investigated carbapenemase genotypes, outer membrane porin alterations, and novel beta-lactamase inhibitor susceptibility among clinical intensive care isolates. Blood and respiratory cultures from 132 hospitalized adults were analyzed via multiplex polymerase chain reaction, broth microdilution, and whole-genome sequencing. BlaKPC-2 and blaKPC-3 genes predominated in 68.2 percent of carbapenem-resistant isolates, while ceftazidime-avibactam retained 93.9 percent in vitro activity. Targeted antimicrobial stewardship and contact isolation curtail hospital transmission.
Keywords: Enterobacter cloacae, Carbapenemase, Ceftazidime-avibactam, Intensive care infection, Antimicrobial resistance
Citation: Adewale K, Lindqvist B, Kulkarni S (2026). Genomic surveillance and ceftazidime-avibactam susceptibility of KPC-producing Enterobacter cloacae complex in intensive care units. African Journal of Infectious Diseases Research, 13(11): 772–779. DOI: 10.46882/AJIDR/149014
Manuscript Timeline: Received: September 05, 2026; Revised: October 06, 2026; Accepted: November 02, 2026; Published: November 07, 2026
African Journal of Infectious Diseases Research | Vol. 13, No. 10, October 2026 | pp. 764–771
DOI: 10.46882/AJIDR/149013
Article Type: Research Article
Title: Prevalence, serotype distribution, and antibiotic resistance of group B Streptococcus colonization in late-pregnancy women
Names of Authors: Chidinma Nwankwo¹*, Henriette Weber², Hiroshi Tanaka³
Abstract: Maternal rectovaginal colonization with Streptococcus agalactiae is the primary risk factor for invasive early-onset neonatal sepsis and meningitis. We determined maternal colonization rates, capsular polysaccharide serotypes, and clindamycin resistance profiles during late gestation. Rectovaginal swabs from 460 pregnant women at 35 to 37 weeks of gestation were cultured in selective broth and subjected to multiplex capsular typing. Colonization prevalence was 21.3 percent, with serotypes Ia, III, and V comprising 76.5 percent of isolates and inducible clindamycin resistance observed in 24.5 percent. Universal antenatal screening and intrapartum penicillin prophylaxis prevent neonatal morbidity.
Keywords: Streptococcus agalactiae, Group B Streptococcus, Maternal colonization, Neonatal sepsis, Intrapartum prophylaxis
Citation: Nwankwo C, Weber H, Tanaka H (2026). Prevalence, serotype distribution, and antibiotic resistance of group B Streptococcus colonization in late-pregnancy women. African Journal of Infectious Diseases Research, 13(10): 764–771. DOI: 10.46882/AJIDR/149013
Manuscript Timeline: Received: September 01, 2026; Revised: September 29, 2026; Accepted: October 21, 2026; Published: October 29, 2026
African Journal of Infectious Diseases Research | Vol. 13, No. 10, October 2026 | pp. 756–763
DOI: 10.46882/AJIDR/149012
Article Type: Research Article
Title: Molecular characterization and benznidazole treatment response in chronic Trypanosoma cruzi Chagas cardiomyopathy
Names of Authors: Valentina Rojas¹*, Babatunde Ojo², Anders Lindqvist³
Abstract: Chagas disease caused by the protozoan parasite Trypanosoma cruzi leads to progressive dilated cardiomyopathy and conduction abnormalities decades after initial infection. We evaluated discrete typing unit distribution, parasitemia clearance, and cardiac biomarker trajectories following benznidazole therapy. Peripheral blood samples from 148 seropositive adults were analyzed via satellite DNA quantitative polymerase chain reaction and echocardiography. Discrete typing units TcII and TcV predominated, with sustained parasitological clearance achieved in 81.8 percent of treated patients at 12 months. Antitrypanosomal chemotherapy halts parasitemia and slows myocardial progression.
Keywords: Trypanosoma cruzi, Chagas cardiomyopathy, Benznidazole, Discrete typing units, Neglected tropical diseases
Citation: Rojas V, Ojo B, Lindqvist A (2026). Molecular characterization and benznidazole treatment response in chronic Trypanosoma cruzi Chagas cardiomyopathy. African Journal of Infectious Diseases Research, 13(10): 756–763. DOI: 10.46882/AJIDR/149012
Manuscript Timeline: Received: August 29, 2026; Revised: September 27, 2026; Accepted: October 19, 2026; Published: October 26, 2026
African Journal of Infectious Diseases Research | Vol. 13, No. 10, October 2026 | pp. 740–747
DOI: 10.46882/AJIDR/149010
Article Type: Research Article
Title: Antimicrobial resistance profiles and fluoroquinolone target mutations in Campylobacter jejuni and Campylobacter coli enteritis
Names of Authors: Priya Subramanian¹*, Kwesi Mensah², Lukas Novak³
Abstract: Campylobacter species are leading bacterial etiologies of foodborne gastroenteritis worldwide, increasingly complicated by resistance to macrolides and fluoroquinolones. We evaluated species prevalence, gyrA mutations, and erythromycin susceptibility among patients presenting with acute inflammatory diarrhea. Stool samples from 390 outpatients were cultured under microaerophilic conditions and analyzed via multiplex polymerase chain reaction and sequencing. Campylobacter jejuni accounted for 81.4 percent of isolates, with the C257T gyrA mutation conferring ciprofloxacin resistance in 69.8 percent of strains while erythromycin resistance remained at 6.2 percent. Erythromycin remains the preferred empirical agent when antibiotic therapy is indicated.
Keywords: Campylobacter jejuni, Foodborne gastroenteritis, Fluoroquinolone resistance, GyrA mutation, Antimicrobial susceptibility
Citation: Subramanian P, Mensah K, Novak L (2026). Antimicrobial resistance profiles and fluoroquinolone target mutations in Campylobacter jejuni and Campylobacter coli enteritis. African Journal of Infectious Diseases Research, 13(10): 740–747. DOI: 10.46882/AJIDR/149010
Manuscript Timeline: Received: August 25, 2026; Revised: September 22, 2026; Accepted: October 15, 2026; Published: October 21, 2026
African Journal of Infectious Diseases Research | Vol. 13, No. 10, October 2026 | pp. 748–755
DOI: 10.46882/AJIDR/149011
Article Type: Research Article
Title: Serological surveillance and clinical predictors of Crimean-Congo hemorrhagic fever virus infection in tick-exposed rural populations
Names of Authors: Amina Bakare¹*, Dimitri Volkov², Fatima Al-Mansoor³
Abstract: Crimean-Congo hemorrhagic fever is a severe tick-borne viral zoonosis characterized by sudden fever, thrombocytopenia, and hemorrhagic manifestations with high case fatality. We assessed anti-viral immunoglobulin G seroprevalence, tick vector infection rates, and clinical severity markers in endemic agro-pastoral districts. Serum samples from 350 residents and 620 Hyalomma ticks were tested via enzyme-linked immunosorbent assay and reverse transcription polymerase chain reaction. Human seropositivity reached 14.3 percent, while viral RNA was detected in 4.5 percent of pooled ticks. Early ribavirin administration and tick bite prevention mitigate severe clinical outcomes.
Keywords: Crimean-Congo hemorrhagic fever, Hyalomma ticks, Viral hemorrhagic fever, Tick-borne zoonosis, Serosurveillance
Citation: Bakare A, Volkov D, Al-Mansoor F (2026). Serological surveillance and clinical predictors of Crimean-Congo hemorrhagic fever virus infection in tick-exposed rural populations. African Journal of Infectious Diseases Research, 13(10): 748–755. DOI: 10.46882/AJIDR/149011
Manuscript Timeline: Received: August 27, 2026; Revised: September 25, 2026; Accepted: October 17, 2026; Published: October 24, 2026
African Journal of Infectious Diseases Research | Vol. 13, No. 10, October 2026 | pp. 732–739
DOI: 10.46882/AJIDR/149009
Article Type: Research Article
Title: Molecular epidemiology and amphotericin B susceptibility of Histoplasma capsulatum in progressive disseminated histoplasmosis
Names of Authors: Mateo Silva¹*, Zainab Abubakar², Stefan Lindqvist³
Abstract: Progressive disseminated histoplasmosis is a life-threatening systemic endemic mycosis that frequently mimics disseminated tuberculosis in immunocompromised hosts. We determined fungal antigen sensitivity, internal transcribed spacer clades, and antifungal minimum inhibitory concentrations among patients with advanced immunosuppression. Urine, bone marrow, and blood specimens from 110 suspected cases were examined via Histoplasma galactomannan enzyme immunoassay and broth microdilution. Disseminated histoplasmosis was confirmed in 23.6 percent of patients, with liposomal amphotericin B and itraconazole showing uniform in vitro potency. Rapid urinary antigen screening reduces diagnostic delays and early mortality.
Keywords: Histoplasma capsulatum, Disseminated histoplasmosis, Endemic mycosis, Fungal antigen, Antifungal susceptibility
Citation: Silva M, Abubakar Z, Lindqvist S (2026). Molecular epidemiology and amphotericin B susceptibility of Histoplasma capsulatum in progressive disseminated histoplasmosis. African Journal of Infectious Diseases Research, 13(10): 732–739. DOI: 10.46882/AJIDR/149009
Manuscript Timeline: Received: August 22, 2026; Revised: September 20, 2026; Accepted: October 12, 2026; Published: October 19, 2026